Sex differences in DNMT3A-mutant clonal hematopoiesis and the effects of estrogen
Cell Reports · 2025-04 · 44 (4) · 115494
DOI: 10.1016/j.celrep.2025.115494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-04. Verfasst von Julia Stomper und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Estrogens, DNA (Cytosine-5-)-Methyltransferases, Clonal Hematopoiesis, Mutation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, National Institutes of Health, Gunnar Nilsson Cancer Foundation.
Abstract (Originalsprache)
Blood cancers are generally more common in males, and the prevalence of most mutations that drive clonal hematopoiesis and myeloid malignancies is higher in males. In contrast, hematopoietic DNMT3A mutations are more common in females. Among ∼450,000 participants in the UK Biobank, the prevalence of DNMT3A mutations and copy-number abnormalities is higher in females than males. In a murine model, Dnmt3a-mutant hematopoietic stem cells (HSCs) from unperturbed female mice had increased stemness gene expression compared to male and wild-type (WT) mice. Estrogen regulates HSCs, and we found that Dnmt3a mutations maintain stemness in the setting of estrogen-induced proliferative stress. Dnmt3a-mutant myeloid cells outcompeted WT cells under chronic estrogen treatment, an effect that was dependent on cell-intrinsic estrogen receptor alpha activity. Our studies indicate that estrogen might contribute to the female predominance of DNMT3A-mutant clonal hematopoiesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Broad Institute, Cambridge, MA 02142, USA; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, 40530 Gothenburg, Sweden; SciLifeLab, University of Gothenburg, 40530 G…
- Department of Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, 40530 Gothenburg, Sweden.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Boston, MA 02215, USA. Electronic address: benjamin_ebert@…
Förderung
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
- National Institutes of Health
- Gunnar Nilsson Cancer Foundation
- Howard Hughes Medical Institute
- California Department of Fish and Game
- Dana-Farber Cancer Institute
- Vetenskapsrådet
- German Research Foundation
Zitieren
APA
Stomper, J., Niroula, A., Belizaire, R., McConkey, M., Bandaru, T. S., & Ebert, B. L. (2025). Sex differences in DNMT3A-mutant clonal hematopoiesis and the effects of estrogen. Cell Reports, 44(4), 115494. https://doi.org/10.1016/j.celrep.2025.115494
Vancouver
Stomper J, Niroula A, Belizaire R, McConkey M, Bandaru TS, Ebert BL. Sex differences in DNMT3A-mutant clonal hematopoiesis and the effects of estrogen. Cell Reports. 2025;44(4):115494. doi:10.1016/j.celrep.2025.115494
BibTeX
@article{Stomper2025,
author = {Stomper, Julia and Niroula, Abhishek and Belizaire, Roger and McConkey, Marie and Bandaru, Tagore Sanketh and Ebert, Benjamin L},
title = {Sex differences in DNMT3A-mutant clonal hematopoiesis and the effects of estrogen},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {4},
pages = {115494},
doi = {10.1016/j.celrep.2025.115494}
}
EUVIMED